Test cream and injection treatment for skin squamous cell cancer
Treatments studied
Part of Cancer clinical trials.
This early-phase study tests whether combining an injection into the skin lesion with a topical cream can treat squamous cell skin cancer. It may help shrink the cancer and improve control in people whose tumor is in the lower legs or feet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have biopsy-confirmed squamous cell skin cancer (SCC) on your lower leg (knee and below), measuring between 1 and 2 cm.
- You must be at least 18 years old and able to sign informed consent.
- You should be healthy enough for study treatment, with an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1.
- You cannot be taking any other study drug or device at the same time.
- You cannot have cancer that has spread to lymph nodes or other parts of the body.
- If you can become pregnant, you must have a negative pregnancy test before treatment and use effective birth control during the study and for 120 days after the last dose. If you are not past childbearing potential or are not surgically sterile, you also must avoid pregnancy throughout this period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether delivering chemotherapy through tiny skin needles (microneedles) can shrink or control cutaneous squamous cell cancer (cSCC) that can be surgically treated. Because it’s Phase 1/2, the main goals are to check safety and find the best way to deliver the treatment.
This study tests whether 5-fluorouracil and calcipotriene (medicines used on the skin) can treat certain small, early skin cancers or pre-cancers without surgery. It’s for specific types and locations of lesions and aims to see how well the treatment works and how safe it is.
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
This trial tests a combination of two targeted drugs (an immunotherapy and an EGFR inhibitor) given before surgery to shrink locally advanced skin cancer and potentially make surgery easier or more successful. It may help people whose skin cancer is hard to treat with surgery alone.
This trial tests a combination of an immunotherapy drug (cemiplimab) and a special kind of radiation for a type of skin cancer called cutaneous squamous cell carcinoma. It is designed for people whose cancer has come back or is hard to treat with standard surgery or radiation.
This trial tests if adding calcipotriol to a standard chemotherapy cream (5-fluorouracil) works better than the standard cream alone for treating actinic keratosis (precancerous sun-damaged skin spots). You may qualify if you have at least four spots on your face, scalp, neck, chest, or arms.
Hear when a new Carcinoma, Squamous Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.